Host |
Mouse |
Clone |
ZM53 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Pretreatment |
Citrate or EDTA |
Positive control |
Ovarian carcinoma. |
Dilution |
1:100 - 1:200 |
Isotype |
IgG1 /κ |
Immunogen |
Full length native CA125 protein purified from human ovarian carcinoma |
Localization |
Extracellular membrane-associated. |
CA 125/ MUC16
|
Zeta Corporation |
ZM53 |
0.1 ml |
Concentrate |
CE/IVD |
Z2363MT |
-
|
Host |
Rabbit |
Clone |
ZR367 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Normal renal tissue |
Dilution |
1:100 - 1:200 |
Isotype |
IgG |
Immunogen |
Recombinant human CA9 protein fragment (around aa 314-410) (exact sequence is proprietary) |
Localization |
Cell surface |
CA IX
|
Zeta Corporation |
ZR367 |
1 ml |
Concentrate |
CE/IVD |
Z2740RL |
-
|
Host |
Rabbit |
Clone |
ZR367 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Normal renal tissue |
Dilution |
- |
Isotype |
IgG |
Immunogen |
Recombinant human CA9 protein fragment (around aa 314-410) (exact sequence is proprietary) |
Localization |
Cell surface |
CA IX
|
Zeta Corporation |
ZR367 |
7 ml |
Concentrate |
CE/IVD |
Z2740RP |
-
|
Host |
Rabbit |
Clone |
ZR367 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Normal renal tissue |
Dilution |
1:100 - 1:200 |
Isotype |
IgG |
Immunogen |
Recombinant human CA9 protein fragment (around aa 314-410) (exact sequence is proprietary) |
Localization |
Cell surface |
CA IX
|
Zeta Corporation |
ZR367 |
0.5 ml |
Concentrate |
CE/IVD |
Z2740RS |
-
|
Host |
Rabbit |
Clone |
ZR367 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Normal renal tissue |
Dilution |
1:100 - 1:200 |
Isotype |
IgG |
Immunogen |
Recombinant human CA9 protein fragment (around aa 314-410) (exact sequence is proprietary) |
Localization |
Cell surface |
CA IX
|
Zeta Corporation |
ZR367 |
0.1 ml |
Concentrate |
CE/IVD |
Z2740RT |
-
|
Host |
Mouse |
Clone |
121SLE |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Colon carcinoma. |
Dilution |
1:100 - 1:200 |
Isotype |
IgM |
Immunogen |
Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B-patient (0Le) |
Localization |
Cytoplasm |
CA19-9
|
Zeta Corporation |
121SLE |
1.0 ml |
Concentrate |
CE/IVD |
Z2072ML |
-
|
Host |
Mouse |
Clone |
121SLE |
Format |
Ready-to-use |
Reactivity |
- |
Method |
P |
Positive control |
Colon carcinoma. |
Dilution |
- |
Isotype |
IgM |
Immunogen |
Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B-patient (0Le) |
Localization |
Cytoplasm |
CA19-9
|
Zeta Corporation |
121SLE |
7 ml |
Ready-to-use |
CE/IVD |
Z2072MP |
-
|
Host |
Mouse |
Clone |
121SLE |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Colon carcinoma. |
Dilution |
1:100 - 1:200 |
Isotype |
IgM |
Immunogen |
Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B-patient (0Le) |
Localization |
Cytoplasm |
CA19-9
|
Zeta Corporation |
121SLE |
0.5 ml |
Concentrate |
CE/IVD |
Z2072MS |
-
|
Host |
Mouse |
Clone |
121SLE |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Colon carcinoma. |
Dilution |
1:100 - 1:200 |
Isotype |
IgM |
Immunogen |
Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B-patient (0Le) |
Localization |
Cytoplasm |
CA19-9
|
Zeta Corporation |
121SLE |
0.1 ml |
Concentrate |
CE/IVD |
Z2072MT |
-
|
Host |
Mouse |
Clone |
CH-19 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Pepsin |
Positive control |
Tonsil |
Dilution |
1:25 - 1:50 |
Isotype |
Mouse IgG1 |
Localization |
Cell Membrane |
Cadherin (Pan)
|
Diagnostic Biosystems |
CH-19 |
1 ml |
Concentrate |
CE/IVD |
MOB228 |
-
|
Host |
Mouse |
Clone |
CH-19 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Pepsin |
Positive control |
Tonsil |
Dilution |
1:25 - 1:50 |
Isotype |
Mouse IgG1 |
Localization |
Cell Membrane |
Cadherin (Pan)
|
Diagnostic Biosystems |
CH-19 |
0.1 ml |
Concentrate |
CE/IVD |
MOB228-01 |
-
|
Host |
Mouse |
Clone |
CH-19 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Pepsin |
Positive control |
Tonsil |
Dilution |
1:25 - 1:50 |
Isotype |
Mouse IgG1 |
Localization |
Cell Membrane |
Cadherin (Pan)
|
Diagnostic Biosystems |
CH-19 |
0.5 ml |
Concentrate |
CE/IVD |
MOB228-05 |
-
|
Host |
Mouse |
Clone |
1H3 |
Format |
Concentrate |
Method |
P |
Pretreatment |
Diva modified Citrate pH 6.2 |
Positive control |
Colon Carcinoma |
Dilution |
1:100 - 1:200 |
Isotype |
Mouse IgG1/κ |
Localization |
Cytoplasm and Cell Membrane |
Cadherin 17
|
Biocare Medical |
1H3 |
0.1 ml |
Concentrate |
CE/IVD |
ACI3111A |
-
|
Host |
Mouse |
Clone |
1H3 |
Format |
Concentrate |
Method |
P |
Pretreatment |
Diva modified Citrate pH 6.2 |
Positive control |
Colon Carcinoma |
Dilution |
1:100 - 1:200 |
Isotype |
Mouse IgG1/κ |
Localization |
Cytoplasm and Cell Membrane |
Cadherin 17
|
Biocare Medical |
1H3 |
1 ml |
Concentrate |
CE/IVD |
ACI3111C |
-
|
Host |
Mouse |
Clone |
1H3 |
Format |
Ready-to-use |
Method |
P |
Pretreatment |
Diva modified Citrate pH 6.2 |
Positive control |
Colon Carcinoma |
Dilution |
- |
Isotype |
Mouse IgG1/κ |
Localization |
Cytoplasm and Cell Membrane |
Cadherin 17
|
Biocare Medical |
1H3 |
6 ml |
Ready-to-use |
CE/IVD |
API3111AA |
-
|
Host |
Mouse |
Clone |
CB-955 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate, Enzyme |
Positive control |
Kidney |
Dilution |
1:150 - 1:300 |
Isotype |
Mouse IgG1 |
Immunogen |
Purified bovine kidney calbindin-D-28K |
Localization |
Cytoplasm, Cell Membrane |
Calbindin
|
Diagnostic Biosystems |
CB-955 |
1 ml |
Concentrate |
CE/IVD |
MOB554 |
-
|
Host |
Mouse |
Clone |
CB-955 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate, Enzyme |
Positive control |
Kidney |
Dilution |
1:150 - 1:300 |
Isotype |
Mouse IgG1 |
Immunogen |
Purified bovine kidney calbindin-D-28K |
Localization |
Cytoplasm, Cell Membrane |
Calbindin
|
Diagnostic Biosystems |
CB-955 |
0.1 ml |
Concentrate |
CE/IVD |
MOB554-01 |
-
|
Host |
Mouse |
Clone |
CB-955 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate, Enzyme |
Positive control |
Kidney |
Dilution |
1:150 - 1:300 |
Isotype |
Mouse IgG1 |
Immunogen |
Purified bovine kidney calbindin-D-28K |
Localization |
Cytoplasm, Cell Membrane |
Calbindin
|
Diagnostic Biosystems |
CB-955 |
0.5 ml |
Concentrate |
CE/IVD |
MOB554-05 |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Thyroid, Medullary Carcinoma |
Dilution |
1:300 |
Isotype |
Rabbit IgG |
Immunogen |
Synthetic human calcitonin 1-32 amino acid peptide. |
Localization |
Cytoplasm |
Calcitonin
|
Zytomed Systems GmbH |
polyclonal |
1 ml |
Concentrate |
RUO |
503-1154 |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Ready-to-use |
Method |
F, P |
Positive control |
Thyroid |
Dilution |
- |
Isotype |
Rabbit IgG |
Localization |
Cytoplasm |
Calcitonin
|
Diagnostic Biosystems |
polyclonal |
6 ml |
Ready-to-use |
CE/IVD |
PDR024 |
-
|
Host |
Rabbit |
Clone |
SP17 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Medullary thyroid carcinoma |
Dilution |
1:100 |
Isotype |
Rabbit IgG |
Immunogen |
Synthetic peptide of 32 amino acid residues corresponding to human Calcitonin |
Localization |
Cytoplasm |
Calcitonin
|
Zytomed Systems GmbH |
SP17 |
1 ml |
Concentrate |
RUO |
RBK038 |
-
|
Host |
Rabbit |
Clone |
SP17 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Medullary thyroid carcinoma |
Dilution |
1:100 |
Isotype |
Rabbit IgG |
Immunogen |
Synthetic peptide of 32 amino acid residues corresponding to human Calcitonin |
Localization |
Cytoplasm |
Calcitonin
|
Zytomed Systems GmbH |
SP17 |
0.5 ml |
Concentrate |
RUO |
RBK038-05 |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Concentrate |
Method |
F, P |
Positive control |
Thyroid |
Dilution |
1:50 - 1:100 |
Isotype |
Rabbit IgG |
Localization |
Cytoplasm |
Calcitonin
|
Diagnostic Biosystems |
polyclonal |
1 ml |
Concentrate |
CE/IVD |
RP050 |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Concentrate |
Method |
F, P |
Positive control |
Thyroid |
Dilution |
1:50 - 1:100 |
Isotype |
Rabbit IgG |
Localization |
Cytoplasm |
Calcitonin
|
Diagnostic Biosystems |
polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
RP050-01 |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Concentrate |
Method |
F, P |
Positive control |
Thyroid |
Dilution |
1:50 - 1:100 |
Isotype |
Rabbit IgG |
Localization |
Cytoplasm |
Calcitonin
|
Diagnostic Biosystems |
polyclonal |
0.5 ml |
Concentrate |
CE/IVD |
RP050-05 |
-
|
Host |
Mouse |
Clone |
ZM301 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Thyroid or medullary carcinoma |
Dilution |
1:100 - 1:200 |
Isotype |
IgG2b /κ |
Immunogen |
Recombinant fragment of human Calcitonin protein (around aa 3-116) |
Localization |
Cytoplasm |
Calcitonin
|
Zeta Corporation |
ZM301 |
1 ml |
Concentrate |
CE/IVD |
Z2731ML |
-
|
Host |
Mouse |
Clone |
ZM301 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Thyroid or medullary carcinoma |
Dilution |
- |
Isotype |
IgG2b /κ |
Immunogen |
Recombinant fragment of human Calcitonin protein (around aa 3-116) |
Localization |
Cytoplasm |
Calcitonin
|
Zeta Corporation |
ZM301 |
7 ml |
Concentrate |
CE/IVD |
Z2731MP |
-
|
Host |
Mouse |
Clone |
ZM301 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Thyroid or medullary carcinoma |
Dilution |
1:100 - 1:200 |
Isotype |
IgG2b /κ |
Immunogen |
Recombinant fragment of human Calcitonin protein (around aa 3-116) |
Localization |
Cytoplasm |
Calcitonin
|
Zeta Corporation |
ZM301 |
0.5 ml |
Concentrate |
CE/IVD |
Z2731MS |
-
|
Host |
Mouse |
Clone |
ZM301 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Thyroid or medullary carcinoma |
Dilution |
1:100 - 1:200 |
Isotype |
IgG2b /κ |
Immunogen |
Recombinant fragment of human Calcitonin protein (around aa 3-116) |
Localization |
Cytoplasm |
Calcitonin
|
Zeta Corporation |
ZM301 |
0.1 ml |
Concentrate |
CE/IVD |
Z2731MT |
-
|
Host |
Goat |
Clone |
polyclonal |
Format |
Purified |
Method |
IF, P, EL |
Dilution |
1:200 - 1:1600 (P) |
Isotype |
Goat IgG |
Immunogen |
Synthetic rat Tyr-CGRP (23-37) conjugated to gamma globulin |
Calcitonin Gene-Related Peptide (CGRP)
|
Zytomed Systems GmbH |
polyclonal |
100 µl |
Purified |
RUO |
603-0030 |
-
|
Host |
Mouse |
Clone |
hHCD |
Format |
Concentrate |
Method |
P |
Pretreatment |
EDTA |
Positive control |
Endometrial cancer |
Dilution |
1:50 - 1:100 |
Isotype |
IgG1 kappa |
Localization |
Cytoplasm |
Caldesmon
|
Diagnostic Biosystems |
hHCD |
1 ml |
Concentrate |
CE/IVD |
MOB556 |
-
|
Host |
Mouse |
Clone |
hHCD |
Format |
Concentrate |
Method |
P |
Pretreatment |
EDTA |
Positive control |
Endometrial cancer |
Dilution |
1:50 - 1:100 |
Isotype |
IgG1 kappa |
Localization |
Cytoplasm |
Caldesmon
|
Diagnostic Biosystems |
hHCD |
0.1 ml |
Concentrate |
CE/IVD |
MOB556-01 |
-
|
Host |
Mouse |
Clone |
hHCD |
Format |
Concentrate |
Method |
P |
Pretreatment |
EDTA |
Positive control |
Endometrial cancer |
Dilution |
1:50 - 1:100 |
Isotype |
IgG1 kappa |
Localization |
Cytoplasm |
Caldesmon
|
Diagnostic Biosystems |
hHCD |
0.5 ml |
Concentrate |
CE/IVD |
MOB556-05 |
-
|
Host |
Mouse |
Clone |
hHCD |
Format |
Ready-to-use |
Method |
P |
Pretreatment |
EDTA |
Positive control |
Endometrial cancer |
Dilution |
- |
Isotype |
IgG1 kappa |
Localization |
Cytoplasm |
Caldesmon
|
Diagnostic Biosystems |
hHCD |
6 ml |
Ready-to-use |
CE/IVD |
PDM223 |
-
|
Host |
Mouse |
Clone |
hHCD |
Format |
Ready-to-use |
Method |
P |
Pretreatment |
EDTA |
Positive control |
Endometrial cancer |
Dilution |
- |
Isotype |
IgG1 kappa |
Localization |
Cytoplasm |
Caldesmon
|
Diagnostic Biosystems |
hHCD |
25 ml |
Ready-to-use |
CE/IVD |
PDM223-25 |
-
|
Host |
Mouse |
Clone |
ZM79 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Uterus, colon carcinoma. |
Dilution |
1:100 - 1:200 |
Isotype |
IgG1 /κ |
Immunogen |
Recombinant full-length human CALD1 protein |
Localization |
Cytoplasm |
Caldesmon
|
Zeta Corporation |
ZM79 |
1.0 ml |
Concentrate |
CE/IVD |
Z2389ML |
-
|
Host |
Mouse |
Clone |
ZM79 |
Format |
Ready-to-use |
Reactivity |
- |
Method |
P |
Positive control |
Uterus, colon carcinoma. |
Dilution |
- |
Isotype |
IgG1 /κ |
Immunogen |
Recombinant full-length human CALD1 protein |
Localization |
Cytoplasm |
Caldesmon
|
Zeta Corporation |
ZM79 |
7 ml |
Ready-to-use |
CE/IVD |
Z2389MP |
-
|
Host |
Mouse |
Clone |
ZM79 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Uterus, colon carcinoma. |
Dilution |
1:100 - 1:200 |
Isotype |
IgG1 /κ |
Immunogen |
Recombinant full-length human CALD1 protein |
Localization |
Cytoplasm |
Caldesmon
|
Zeta Corporation |
ZM79 |
0.5 ml |
Concentrate |
CE/IVD |
Z2389MS |
-
|
Host |
Mouse |
Clone |
ZM79 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Uterus, colon carcinoma. |
Dilution |
1:100 - 1:200 |
Isotype |
IgG1 /κ |
Immunogen |
Recombinant full-length human CALD1 protein |
Localization |
Cytoplasm |
Caldesmon
|
Zeta Corporation |
ZM79 |
0.1 ml |
Concentrate |
CE/IVD |
Z2389MT |
-
|
Host |
Rabbit |
Clone |
SP81 |
Format |
Concentrate |
Method |
P |
Pretreatment |
Citrate |
Positive control |
Breast carcinoma |
Dilution |
1:100 |
Isotype |
Rabbit IgG |
Immunogen |
A synthetic peptide derived from internal region of human calpain protein |
Localization |
Cytoplasm |
Calpain
|
Zytomed Systems GmbH |
SP81 |
1 ml |
Concentrate |
RUO |
503-3814 |
-
|
Host |
Mouse |
Clone |
CALP |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Trypsin |
Positive control |
Breast Carcinoma |
Dilution |
1:50 - 1:100 |
Isotype |
Mouse IgG1 |
Localization |
Cytoplasm |
Calponin
|
Diagnostic Biosystems |
CALP |
1 ml |
Concentrate |
CE/IVD |
MOB345 |
-
|
Host |
Mouse |
Clone |
CALP |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Trypsin |
Positive control |
Breast Carcinoma |
Dilution |
1:50 - 1:100 |
Isotype |
Mouse IgG1 |
Localization |
Cytoplasm |
Calponin
|
Diagnostic Biosystems |
CALP |
0.1 ml |
Concentrate |
CE/IVD |
MOB345-01 |
-
|
Host |
Mouse |
Clone |
CALP |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Trypsin |
Positive control |
Breast Carcinoma |
Dilution |
1:50 - 1:100 |
Isotype |
Mouse IgG1 |
Localization |
Cytoplasm |
Calponin
|
Diagnostic Biosystems |
CALP |
0.5 ml |
Concentrate |
CE/IVD |
MOB345-05 |
-
|
Host |
Mouse |
Clone |
CALP |
Format |
Ready-to-use |
Method |
F, P |
Pretreatment |
Trypsin |
Positive control |
Breast Carcinoma |
Dilution |
- |
Isotype |
Mouse IgG1 |
Localization |
Cytoplasm |
Calponin
|
Diagnostic Biosystems |
CALP |
6 ml |
Ready-to-use |
CE/IVD |
PDM219 |
-
|
Host |
Mouse |
Clone |
CALP |
Format |
Ready-to-use |
Method |
F, P |
Pretreatment |
Trypsin |
Positive control |
Breast Carcinoma |
Dilution |
- |
Isotype |
Mouse IgG1 |
Localization |
Cytoplasm |
Calponin
|
Diagnostic Biosystems |
CALP |
25 ml |
Ready-to-use |
CE/IVD |
PDM219-25 |
-
|
Host |
Mouse |
Clone |
ZM21 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Normal breast tissue. |
Dilution |
1:100 - 1:200 |
Isotype |
IgG1 /κ |
Immunogen |
Recombinant human CNN1 protein |
Localization |
Cytoplasm |
Calponin-1
|
Zeta Corporation |
ZM21 |
1.0 ml |
Concentrate |
CE/IVD |
Z2341ML |
-
|
Host |
Mouse |
Clone |
ZM21 |
Format |
Ready-to-use |
Reactivity |
- |
Method |
P |
Positive control |
Normal breast tissue. |
Dilution |
- |
Isotype |
IgG1 /κ |
Immunogen |
Recombinant human CNN1 protein |
Localization |
Cytoplasm |
Calponin-1
|
Zeta Corporation |
ZM21 |
7 ml |
Ready-to-use |
CE/IVD |
Z2341MP |
-
|
Host |
Mouse |
Clone |
ZM21 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Normal breast tissue. |
Dilution |
1:100 - 1:200 |
Isotype |
IgG1 /κ |
Immunogen |
Recombinant human CNN1 protein |
Localization |
Cytoplasm |
Calponin-1
|
Zeta Corporation |
ZM21 |
0.5 ml |
Concentrate |
CE/IVD |
Z2341MS |
-
|
Host |
Mouse |
Clone |
ZM21 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Normal breast tissue. |
Dilution |
1:100 - 1:200 |
Isotype |
IgG1 /κ |
Immunogen |
Recombinant human CNN1 protein |
Localization |
Cytoplasm |
Calponin-1
|
Zeta Corporation |
ZM21 |
0.1 ml |
Concentrate |
CE/IVD |
Z2341MT |
-
|
Host |
Rabbit |
Clone |
ZR297 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Normal breast tissue |
Dilution |
1:100 - 1:200 |
Isotype |
IgG |
Immunogen |
Recombinant human full-length CNN1 protein |
Localization |
Cytoplasm |
Calponin-1
|
Zeta Corporation |
ZR297 |
1 ml |
Concentrate |
CE/IVD |
Z2612RL |
-
|